|
|
Patients treated with interferon alfa can developed autoantibodies and autoimmune diseases.We describe two patients who developed myasthenia gravis with abnormal levels of serum anti-acetylcholine receptor antibodies during interferon alfa-2b treatment for malignancies.One of these patients had myopathic findings on EMG and focal deficiency of cytochrome c oxidase on muscle biopsy. |
|